Device Trial Radar · NCT06947447
WatchPAT SpO2 Validation Study
Last checked: Nov 20, 2026Latest source record: Aug 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
Apr 21, 2025
Primary completion
May 2, 2025
Study completion May 2, 2025
Sponsor
- Lead sponsor
- Itamar-Medical, IsraelNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Element Materials Technology
- First posted
- Apr 27, 2025
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Validate the SpO2 accuracy of the WatchPAT compared to arterial blood CO-Oximetry
Conditions
- Healthy
Interventions
No interventionDevice
Device
Primary outcomes
What the sponsor says the trial is designed to measure.
- SpO2 AccuracyTime frame: April-May 2025
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Element Materials Technology
Louisville, Colorado
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.